A comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis

Cancer Risk from Bone Morphogenetic Protein Exposure in Spinal Arthrodesis

(2014) Mick P Kelly et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Editorial: Methodology and reporting of meta-analyses in the neurosurgical literature

(2014) John H. Sampson et al.   JOURNAL OF NEUROSURGERY

Methodology and reporting of meta-analyses in the neurosurgical literature

(2014) Paul Klimo et al.   JOURNAL OF NEUROSURGERY

Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion

(2013) Mark C. Simmonds et al.   ANNALS OF INTERNAL MEDICINE

Effectiveness and Harms of Recombinant Human Bone Morphogenetic Protein-2 in Spine Fusion

(2013) Rongwei Fu et al.   ANNALS OF INTERNAL MEDICINE

Cancer Risk After Use of Recombinant Bone Morphogenetic Protein-2 for Spinal Arthrodesis

(2013) Eugene J Carragee et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

High-Dose rhBMP-2 for Adults: Major and Minor Complications

(2013) Addisu Mesfin et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Cancer After Spinal Fusion

(2013) Shivanand P. Lad et al.   NEUROSURGERY

Risk of Cancer After Lumbar Fusion Surgery With Recombinant Human Bone Morphogenic Protein-2 (rh-BMP-2)

(2013) Gregory S. Cooper et al.   SPINE

rhBMP-2 for Posterolateral Instrumented Lumbar Fusion

(2013) R. John Hurlbert et al.   SPINE

Delayed onset of paralysis and slowed tumor growth following in situ placement of recombinant human bone morphogenetic protein 2 within spine tumors in a rat model of metastatic breast cancer

(2012) Camilo A. Molina et al.   JOURNAL OF NEUROSURGERY-SPINE

A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned

(2011) Eugene J. Carragee et al.   Spine Journal

Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion

(2010) Nan-Fu Chen et al.   JOURNAL OF NEUROSURGERY-SPINE

Bone Morphogenetic Proteins and Cancer

(2010) Jayesh P. Thawani et al.   NEUROSURGERY

Recombinant human bone morphogenetic protein-2 and pancreatic cancer: a retrospective cohort study

(2010) Daniel Mines et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Off-Label Use of Bone Morphogenetic Proteins in the United States Using Administrative Data

(2010) Kevin L. Ong et al.   SPINE

A COMPREHENSIVE REVIEW OF THE SAFETY PROFILE OF BONE MORPHOGENETIC PROTEIN IN SPINE SURGERY

(2010) David Benglis et al.   Operative Neurosurgery

Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures

(2009) Kevin S. Cahill   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical and Radiographic Analysis of an Optimized rhBMP-2 Formulation as an Autograft Replacement in Posterolateral Lumbar Spine Arthrodesis

(2009) John R Dimar et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME